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Neurogenic inflanunation. in its original definition. 
the plasma leakage induced by stimulation of periph­
eral sensory nerves. occurs in the postcapillary 
venules of the skin and airways. Plasm" leakage is 
accompanied by increased blood flow. which results 
from dilatation of arterioles. In skin. these phenom­
ena are manifested as wheal and flare. respectively. 
Both phenomena are mediated by neuropeptides re­
leased from capsaicin-sensitive unmyelinated sensory 
nerve fibers. Substance P is the primary mediator 
responsible for pla.ma leakage. acting via tachykinin 
NK-l receptors. whereas both calcitonm. gene-re­
lated peptide and substance P induce vasodilatation. 
Sensory nerve transmitters also cause release of his­
tamine from mast cells. which contributes substan­
tially to plasma leakage in the skin. but less so in the 
airways. Substance P causes an increase in vascular 
T he goal of this chapter is to review the discovery of neurogenic inflammation and to outline the mecha­nisms that mediate plasma leakage and vasodilata­tion. Examples of the nerves and blood vessels involved in these phenomena are presented from the 
skin and airways. Readers interested in learning more about 
neurogenic inflammation are referred to several excellent reviews 
(ChaW, 1988; Maggi and Meli, 1988; Geppetti and Holzer, 1996; 
Lundberg, 1996; McDonald, 1994a, 1997). 
HISTORY OF NEUROGENIC INFLAMMATION 
The four cardinal signs of inflammation recognized since antiquity 
are redness, swelling, heat, and pain. The first three signs clearly 
involve blood vessels, resulting from vasodilatation, hyperemia, 
and increased vascular permeability, whereas the fourth sign in­
volves sensory nerVes. Inflammation can be induced by a wide 
variety of stimuli, including direct mechanical damage of tissues, 
exposure to bacterial toxins or exogenous chemical irritants, and by 
the release of endogenous inflammatory mediators. 
Increased blood flow, as evidenced by redness and heat in the 
skin resulting from antidromic stimulation of the cut ends of 
sensory nerves, has been known for more than a century. The 
discovery of neurogenic inflammation as we know it today, how­
ever, is usually credited to Ninian Bruce, although he did not use 
this exact term for this phenomenon. He demonstrated that topical 
application of irritants to the conjunctiva and skin of cats and rabbits 
produced not only redness and heat, but also swelling, and that 
these effects depended on an intact sensory nerve supply (Bruce, 
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permeability as a result of the focal. transient. and 
fully reversible formation of gaps. approximately 0.5 
to 1.5 p.m in diameter. located in the intercellular 
junctions of endothelial cells. The gaps can be visu­
alized by silver nitrate staining of the endothelial cell 
borders. by lectin staining. or by scanning and trans­
mission electron microscopy. Neurogenic inflanuna­
tion can be inhibited by preventing the stimulation of 
sensory nerves. by presynaptic inhibition of neu­
ropeptide release from sensory nerves. or by blocking 
neuropeptide receptors. The formation of endothe­
lial gaps can also be inhibited by anti-infl."mmatory 
drugs that stabilize endothelial cells. such as f3-ad­
renergic agonists and steroids. Key words: substance 
P/sensory nerves/plasma leakage/capsaicin. Journal of Inves­
tigative Dermatology Symposium Proceedings 2:76-81, 
1997 
1913). Bruce correctly proposed that the response was based on a 
peripheral axon reflex (Fig 1). Lewis (1927) noted that the flare 
component of the triple response in human skin, Le., the vasodi­
latation spreading around the original site of stimulation was 
dependent on an intact sensory nerve supply and was abolished by 
local anesthesia. Lewis proposed the concept of sensory nerves with 
a 'nocifensor' or defense function many years before the sensory 
transmitters involved were chemically identified. Studies on neu­
rogenic plasma leakage, however, were not continued, and until 
the 1960s it was generally believed that the influence of the nervous 
system on inflammation was restricted to vasodilatation (Lembeck, 
1983; Szolcsanyi, 1984). For example, in the 1950s evidence was 
presented that the vasodilatation resulting from antidromic stimu­
lation of sensory nerves was caused by ATP liberated from the 
nerves (Holton, 1959). 
Interest in neurogenic inflammation was rekindled by the pio­
neering work of the Hungarian scientist Nicholas Jancs6, who 
made several important discoveries and technical innovations: (i) 
He coined the term "neurogenic inflammation" to describe the 
inflammatory response induced in the skin by direct electrical 
stimulation of sensory nerves or by stimulation of the nerves by 
chemical irritants, such as capsaicin, mustard oil, formalin, xylene, 
or hypertonic solutions (Jancs6, 1960; Jancs6 et aI, 1967). (ii) He 
noted that these inflammatory stimuli produced not only vasodila­
tation, but also increased vascular permeability, and that the effects 
were not blocked by cholinergic or adrenergic antagonists. (iii) He 
introduced the Evans blue method for quantifying plasma leakage 
and a histologic method for labeling leaky blood vessels with 
colloidal pigments. (iv) Jancs6 introduced the use of capsaicin, the 
irritant constituent of hot peppers, as a specific tool to stimulate 
sensory nerves, when administered in low doses, and to desensitize 
or destroy them, when administered in higher doses. After desen-
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Figure 1. Diagrant illustrating the concept of an axon reflex­
ntediating antidrontic vasodilatation in the skin. [From Bruce (1913). 
Vaso-dilator axon reflexes. Q J Exp Physiol 6:339-354.] 
sitization with capsaicin, antidromic nerve stimulation or sensory 
nerve irritants failed to induce inflammation or pain. (v) He noted 
that after stimulation with low doses of capsaicin, the pain threshold 
of sensory nerve fibers was decreased, i.e., the fibers became 
sensitized and the individuals developed hyperalgesia. (vi) Jancso 
clearly recognized that some inflammatory mediators, e.g., capsa­
icin, acted through a neurogenic mechanism, whereas others, e.g., 
histamine, acted through a non-neurogenic mechanism. Jancso 
proposed that for "many inflammation-causing substances, . . .  the 
inflammation is mediated entirely by the nervous system," and the 
"pain sensory nerve endings are actually the receptors of {the} 
inflammatory reaction" Oancso, 1960). Thus, Jancso laid the basis 
for future studies of the efferent effects of afferent nerves. (vii) He 
proposed that a neurotransmitter or a "neurohumor" was released 
from the sensory nerve terminals, but its chemical identity eluded 
him. Unfortunately, the significance of Jancso's work was only 
generally recognized after his death in 1966. For fascinating 
accounts of the early studies of neurogenic inflammation by J ancso 
and others, see Jancso (1960), Jancso et al (1967), Szolcsanyi (1984), 
and Chahl (1988). 
WHICH PHENOMENA CHARACTERIZE NEUROGENIC 
INFLAMMATION? 
For Jancso, the most characteristic sign of neurogenic inflammation 
was clearly the increased vascular permeability that resulted in 
plasma leakage and edema. Although he noted that vasodilatation 
and hyperemia accompanied the increase in vascular permeability, 
he recognized that the former and the latter were separate phe­
nomena, occurring in arterioles and in small venules, respectively. 
Vasodilatation could also occur under many other circumstances 
independently of plasma leakage. Jancso also made the important 
observation that the vasodilatation in skin was abolished by local 
anesthetics, but the neurogenic plasma leakage was not, suggesting 
that these phenomena involved different mechanisms. The purpose 
of neurogenic plasma leakage and vasodilatation is believed to be 
protective. Increased local blood flow may be sufficient to sweep 
away mild irritants, whereas extravasated plasma may help to dilute 
or neutralize stronger irritants and flush them away into lymphatics 
or the airway lumen. If the stimulus is not successfully eliminated, 
however, the inflammatory process may become chronic and 
contribute to pathophysiology, as may be the case in asthma 
(Barnes, 1996). 
Since Jancso's studies, many new effects of sensory nerve trans­
mitters have been discovered, and popular definitions of neuro­
genic inflammation have expanded from the original concept of 
increased plasma leakage and have become somewhat blurred. 
Depending on the organ concerned, in addition to vasodilatation 
and sensory nerve hypersensitivity, other phenomena that have 
become loosely associated with neurogenic inflammation include 
smooth muscle contraction, epithelial cell secretion and ion trans­
port, mast cell degranulation, and the recruitment, vascular adhe­
sion, activation, or migration of leukocytes (McDonald, 1994a). 
Clearly, not all of these phenomena occur in the skin, nor are they 
nose 
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Figure 2. Schentatic diagrant of the ntajor sites of neurogenic 
inflantntation in the rat, as evidenced by the leakage of plasnta 
containing Evans blue dye. 
all likely to be caused by the same mechanisms. There has been 
much interest in the possible role of sensory nerve pep tides in 
bronchoconstriction, a characteristic of asthma (Barnes, 1996). It is 
becoming apparent that, in addition to the direct effects mentioned 
above, sensory neuropeptides have other longer term trophic and 
mitogenic effects on endothelial cells, connective tissue cells, and 
immune ce�s mediated via a variety of receptors and intermediates 
(payan, 1992; Pincelli et ai, 1993; Ziche, 1996; Ansel, 1997). In 
view of the diversity of these phenomena, it may be best to keep 
our definitions clear and to restrict the term "neurogenic inflam­
mation" to the original concept of neurogenically induced plasma 
leakage as proposed by Jancso. 
WHERE DOES NEUROGENIC INFLAMMATION OCCUR? 
Inflammatory changes mediated by sensory nerves have been 
reported in many tissues and organs (Fig 2). These include the skin, 
conjunctiva, meninges and peripheral nerve sheaths, tympanic 
membrane, gingiva, dental pulp, tongue, salivary gland ducts, nasal 
mucosa and airways, esophagus, stomach, gall bladder, bile and 
pancreatic ducts, ureters and urinary bladder, female reproductive 
tract, anal mucosa, and joints (Saria et ai, 1983; Geppetti and 
Holzer, 1996). The common features of many, but not all, of these 
tissues is that they are surfaces of the body facing the external 
environment, which are densely innervated by chemosensitive 
sensory nerves. Another feature is that large differences in sensitiv­
ity occur between regions and among individuals. Neurogenic 
inflammation appears not to occur in the central nervous system, 
most of the gastrointestinal tract, heart, or in skeletal muscle (Saria 
et ai, 1983). 
There are also significant differences in the magnitude and 
distribution of neurogenic inflammation among different species, 
with the phenomenon particularly conspicuous and well studied in 
rats, guinea pigs, and mice (Fig 3). Neurogenic plasma leakage has 
also been reported in the skin of cats, rabbits, pigs, and humans. 
Although neurogenic plasma inflammation is very obvious in 
rodent airways, it is still not clear whether it occurs in human 
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Figure 3. Leaky blood vessels in whole mount preparadons of rat skin and trachea. (A-C) Skin of rat hindpaw after topical application of an irritant 
(5% mustard oil). The particulate tracer Monastral blue is' trapped in the basallarnina of leaky blood vessels. (A) Low magnification view of labeled blood 
vessels, mostly post-capillary venules (�) . Scale bar, 100 p.m. (B) Bundles of varicose substance P-immunoreactive nerve fibers (�) in proximity to Monastral 
blue-labeled blood vessels. Scale bar, 50 /Lm. (C) Mast cells (globular cells intensely stained with toluidine blue indicated by �) in proximity to leaky venules 
labeled with Monastral blue. Note the poor correspondence between the position of the mast cells and the intensity of leakage in nearby vessel segments. 
Scale bar, 50 /Lm. (D-F) Venules in rat trachea after intravenous injection of substance P to cause inflammation. (D) Immunohistochemical localization of 
NK-1 receptors internalized into small dot-like endosomes (�) within the cytoplasm of inflamed venular endothelial cells. Scale bar, 10 /Lm. (B) Mter staining 
with silver nitrate, endothelial cell borders are visualized as solid black lines, and gaps are revealed as dot-like silver deposits (�) in leaky venules. Scale bar, 
10 /Lm. (F) The border between parts of two endothelial cells (top and bottom of photograph) observed en face from the luminal surface by scanning electron 
microscopy. Gaps (�) between the endothelial cells are separated by long endothelial cytoplasmic fingers. The underlying basallarnina is visible through 
some of the gaps. Scale bar, 1 /Lm. [From Baluk et al (1997).] 
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Table I. Stimuli That Activate Sensory Nerves in 
Neurogenic InB.lIIIlIDation 
1. Diret:t activators: electrical stimulation, high K+, low pH, mechanical 
stimuli, heat, ischemia 
2. Plant extracts: capsaicin, resiniferatoxin, mustard oil, nicotine 
3. I'!f/ammatory mediators: histamine, bradykinin, serotonin, arachidonic 
acid metabolites 
4. Noxiaus vapors: cigarette smoke, formaldehyde, acrolein, mustard oil 
vapor, xylene, ether, toluene diisocyanate, allergens, sulfur dioxide, 
cold dry air 
airways (McDonald. 1997). Topical application of irritant chemicals 
such as capsaicin, xylene, mustard oil, or even a piece of very 
pungent paprika to human skin produces a strong burning sensa­
tion, slight edema (wheal), and a flush at the site of application, 
surrounded by an intense flare. Neurogenic inflammation does not 
occur in denervated human skin, e.g., in patients who have 
sustained sensory nerve injury Oancs6 et aI, 1967, 1968). 
SENSORY NERVES THAT EVOKE NEUROGENIC 
INFLAMMATION 
Anatomically, the sensory nerves that mediate antidromic vasodi­
latation and neurogenic plasma extravasation are small diameter 
(A-8) myelinated, and unmyelinated (C) primary aiferent nerve 
fibers. The (small dark B-type) cell bodies of these primary aiferent 
nerve fibers are located in the dorsal root ganglia and in the ganglia 
of cranial nerves. The peripheral nerve fibers are distributed 
somatotopically in the skin with sharply demarcated receptive fields 
(Pinter and Szolcsanyi, 1995). The skin and the airways are richly 
supplied by nerve fibers that contain neuropeptides and other 
transmitters (Wallengren et aI, 1987; Lundberg et aI, 1988; Karanth 
et aI, 1991; Brain, 1996). The number and distribution of sensory 
nerves and their receptors in the skin can change in various 
pathologic conditions, such as psoriasis (Pincelli et aI, 1993). 
MEDIATORS OF NEUROGENIC PLASMA LEAKAGE AND 
VASODILATATION 
Substance P was suspected as a major neurotransmitter of primary 
a1£erent sensory neurons for many years after its discovery by von 
Euler and Gaddum in the 1930s (see Chahl, 1988). This was 
confirmed in the 1970s and 1980s, when substance P was isolated 
and characterized. and antibodies to it became available. Substance 
P satisfies all of the criteria necessary for establishing a candidate 
neurotransmitter as the mediator of neurogenic inflammation 
(Lembeck and Holzer, 1979): (i) It is present in the cell bodies and 
nerve fibers of a population of primary aiferent neurons; (ii) It is 
released from sensory nerve endings upon electrical or chemical 
stimulation of the nerves. In many tissues, release of substance P is 
quite difficult to demonstrate, because endogenous levels are so 
low, or it is rapidly degraded by enzymes. Tachykinin release, 
however, has been shown clearly in the trachea and dental pulp, 
which contain high levels of substance P (Hua and Yaksh, 1992; 
Ohkubo et ai, 1993); (iii) Administration of exogenous substance P 
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produces plasma extravasation and vasodilatation that mimics the 
electrical or chemical stimulation of the sensory nerves (Lembeck 
and Holzer, 1979); (iv) Depletion of substance P by pre-treatment 
with high doses of capsaicin, or blocking the effect of substance P 
with receptor antagonists, blocks the effect of sensory nerve 
stimulation. (v) Inhibiting the enzymes that naturally degrade 
substance P (see below) potentiates the effect of nerve stimulation. 
Intradermal injection of substance P into the human forearm causes 
a dose-dependent wheal and Bare response (Foreman et aI, 1983). 
Subsequent to the identification of substance P as the mediator of 
neurogenic inflanunation, it was discovered that other structurally 
related tachykinins called neurokinin A and neurokinin B, and an 
unrelated peptide calcitonin gene-related peptide (CGRP) , were 
co-localized with substance P within sensory neurons. All of these 
sensory neuropeptides are co-released from sensory nerve endings 
by appropriate stimuli (Hua and Yaksh, 1992; Lou, 1993). All three 
tachykinins evoke plasma leakage if administered in high enough 
concentrations, but substance P is more potent than neurokinin A, 
and neurokinin B is not present in significant amounts in peripheral 
sensory nerves (Chahl, 1988). Substance P, neurokinin A, and 
neurokinin B selectively activate three distinct neurokinin receptors 
termed NK-1, NK-2, and NK-3 receptors. The use of selective 
neurokinin receptor agonists and antagonists has established that 
the plasma leakage and vasodilatation induced by tachykinins are 
both mediated by NK-1 receptors (Lundberg, 1996; Maggi et aI, 
1993). NK-1 receptors have been localized and quantified in 
venular endothelial cells at sites of inflanunation (Bowden et aI, 
1994 and Fig 3D). The biology of the NK-1 receptors is discussed 
in more detail in the article in this volume by Grady et al (1997). 
CGRP by itself does not produce plasma leakage, but does 
induce vasodilatation, acting via CGRP 1 receptors (Brain and 
Williams, 1985; Lundberg, 1996). CGRP, however, potentiates the 
plasma leakage induced by tachykinins in the skin and in the 
airways (Brain and Williams, 1985; Gamse and Saria, 1985), most 
likely by increasing the blood flow. In this respect, CGRP is 
probably not di1ferent from other vasodilators, and the effect is not 
restricted to neurogenic inflammation. For instance, prostaglandin 
El induces hyperemia in guinea pig and rabbit skin and potentiates 
the plasma leakage caused by bradykinin (Kopaniak et aI, 1978). 
The plasma leakage induced in rat skin by substance P is potentiated 
by prostaglandin El and ATP (Chahl, 1977). In addition to its 
effects on blood vessels, CGRP has trophic effects on various cells 
(Ziche, 1996). 
A special feature of some unmyelinated aiferent nerve fibers is 
that they are polymodal, i.e., they can respond to a wide range of 
irritant stimuli listed in Table I. Other unmyelinated aiferent nerve 
fibers, however, respond selectively to low threshold thermal or 
mechanical stimuli (Belmonte and Cervero, 1996). A further 
distinguishing feature of polymodal sensory nerves is that in 
response to stimulation they transmit action potentials both ortho­
dromically to the central nervous system, and antidromically, 
causing the release of transmitters at their peripheral ends (Maggi 
and Meli, 1988; Lundberg, 1996; Maggi, 1996). The dual aiferent­
efferent nature of the sensory nerves is responsible for the action of 
Table D. Comparison of Plasma Leakage and Vasodilatation in Neurogenic Inflammation in Skin 
Feature 
Physical manifestation 
Area alfected 
Blood vessels involved 
Nerve mechanism 
Sensory nerves involved 
Time course to maximum 
Neurotransmitters 
Inhibition by H1 antihistamines 
Mect of local anesthetics 
Mect of tetrodotoxin 
Plasma Leakage 
Wheat or 'tumor' 
Localized 
Postcapillary venules 
'Axon response' 
Capsaicin-sensitive C-fibers 
Long (12 min) 
Substance P 
Small (27%) 
Resistant 
Resistant 
Vasodilatation 
Flare or 'rubor' 
Widespread 
Precapillary arterioles 
'Axon reflex' 
Capsaicin-sensitive A-8 and C-fibers 
Short (3 min) 
Substance P 
CGRP 
Large (78%) 
Inhibited 
Inhibited 
References 
(Foreman et aI, 1983) 
Oancs6 et aI, 1967) 
(Szolcsanyi, 1988, 1996) 
Oiinig and Lisney, 1989) 
(Foreman et aI, 1983) 
(Lembeck and Holzer, 1979) 
(Brain and Williams, 1985) 
(Foreman et aI, 1983) 
(Maggi and Meli, 1988; Szolcsanyi, 1996) 
(Maggi and Meli, 1988; Szolcsanyi, 1996) 
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Table m. Drugs That Inhibit Neurogenic Plasma 
Leakage and Vasodilatation" 
1. Desensitization of sensory nerves or depletion of transmitters 
Chronic treatment with capsaicin or resiniferatoxin 
2. Prevention of sensory nerve activation 
Capsazepine (by blocking capsaicin receptors) 
Ruthenium red (by blocking ion channels) 
Local anesthetics (by preventing nerve conduction) 
Sodium cromoglycate (by stabilizing mast cells) 
3. Presynaptic inhibition of transmitter release 
Opioids acting via lJr-opioid receptors 
Catecholamines acting via u2-adrenoceptors 
Neuropeptide Y acting via Y2 receptors 
GABA acting via GABA2 receptors 
Histamine acting via H3 receptors 
Corticotropin releasing factor and related peptides 
Potassium channel openers 
4. Receptor antagonists 
NK-1 receptor antagonists 
CGRP1 receptor antagonists 
Histamine H1 receptor antagonists 
5. Anti-inflammatory drugs that stabilize endothelial cells 
Steroids 
J3-Adrenergic agonists 
Phosphodiesterase inhibitors and other cAMP-inducing agents 
• For further details see: Barnes (1996), Barnes et al (1991), Lundberg (1996) and 
Maggi and Meli (1988). 
these nerves on blood vessels (Maggi and Meli, 1988). Irritant 
stimuli can act on nerves either directly or indirectly. For instance, 
bradykinin acts mainly by inducing the production of prostaglandin 
intermediates (Geppetti et aI, 1990). Some cytokines, e.g., interleu­
kin 1{3, can potentiate neurogenic inflammation by lowering the 
threshold of sensory nerves to irritant stimuli, i.e., by inducing 
hyperalgesia (Herbert and Holzer, 1994; Lundberg, 1996). 
Capsaicin deserves special consideration among irritant stimuli, 
not only for historical reasons, but because it has been used as a tool 
to dljine the sensory nerves that cause neurogenic inflammation 
(Lundberg, 1996; Maggi, 1996). Capsaicin depolarizes the capsa­
icin-sensitive nerves at low concentrations, probably by activating a 
specific capsaicin receptor and causing a nonselective influx of 
cations. The binding of capsaicin to its receptor and the nonspecific 
cation channel can be blocked by capsazepine and ruthenium red, 
respectively (Lundberg, 1996; Maggi, 1996). At higher concentra­
tions, capsaicin first produces desensitization of the nerves and, 
after chronic application, it causes permanent structural damage. In 
adult animals, only the sensory nerve endings are depleted of 
transmitter, but in newborn animals, entire sensory neurons can be 
permanently destroyed (Jancso et aI, 1985). In both cases there is 
desensitization to further irritant stimuli that act via capsaicin­
sensitive nerves, but there is no effect on the inflammation caused 
by mediators that act directly on blood vessels, or on the perception 
of mechanical stimuli via other nerves that are not sensitive to 
capsaicin (Jancso et aI, 1967). Resiniferatoxin, the ultrapotent 
analog of capsaicin, has a similar, but not identical, spectrum of 
effects and is reviewed elsewhere in this issue by Biro et al (1997). 
COMPARISON OF NEUROGENIC PLASMA LEAKAGE 
AND VASODILATATION 
As noted by Jancso, although neurogenic plasma leakage and 
vasodilatation often occur together and are triggered by the same 
stimuli, they are clearly separate and independent phenomena 
involving different parts of the microvasculature. Antidromic stim­
ulation of sensory nerves at an intensity of 10 V or more and 
frequencies of 1-1 0 Hz induces release of pep tides from the sensory 
nerve fibers (Jancso et aI, 1967; Lundberg and Saria, 1983; Mc­
Donald et aI, 1988) suggesting that A-a (thinly myelinated) and 
C-fibers (unmyelinated) axons are involved. In the skin A-a fibers 
are preferentially responsible for vasodilatation, whereas the C­
fibers are responsible for plasma leakage (Jaoig and Lisney, 1989). 
In rat skin, the threshold to intravenous injection of substance P is 
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approximately one order of magnitude lower for vasodilatation 
than for plasma leakage (Lembeck and Holzer, 1979). Antidromic 
electrical stimulation of sensory nerves can be prevented by local 
anesthetics, such as lidocaine, that block axonal conduction. Inter­
estingly, these same anesthetics do not block the release of trans­
mitter induced by the direct stimulation of sensory nerve endings 
(Jancso et aI, 1967; Szolcsanyi, 1996). Consequently, local anes­
thetics block vasodilatation, which requires an axon rtiflex involving 
nerve conduction, but not plasma leakage, which requires only an 
axon response involving the local release of transmitter from nerve 
fibers but not nerve conduction (Szolcsanyi, 1996). The similarities 
and differences between neurogenic plasma leakage and antidromic 
vasodilatation are summarized in Table II. 
ROLE OF MAST CELLS AND HISTAMINE IN 
NEUROGENIC INFLAMMATION 
Mast cells contribute to neurogenic plasma leakage and vasodila­
tation in some, but not all, tissues where these phenomena have 
been reported and are abundant in skin and airways. In neurogenic 
inflammation, these actions of mast cells are triggered by release of 
transmitters from sensory nerves, mainly substance P (Foreman et 
aI, 1983). Although some mast cells are located close to leaky blood 
vessels or to sensory nerves, other mast cells are distant from either 
blood vessels or sensory nerves (Fig 3C). It is not clear from what 
distance pep tides released from sensory nerves can evoke the 
release of mediators from mast cells and vice versa. Many other 
non-neurogenic stimuli, such as compound 48/80 or allergen 
exposure, can also cause mast cell degranulation. Apparently, 
substance P does not induce the release of histamine via NK-1, 
NK-2, or NK-3 receptors. Instead, the charged N-terminus of the 
substance P molecule has a direct effect on mast cell intracellular 
G-proteins (Mousli et aI, 1990). In human skin, the wheal and flare 
responses to intradermal injections of substance P are both reduced, 
but are not entirely eliminated by pre-treatment with H1 histamine 
antagonists (Foreman et aI, 1983). Thus, it appears that substance P 
has both a direct action on blood vessels and an indirect one, via 
histamine release, from mast cells. Conversely, histamine can also 
evoke plasma leakage by acting directly on endothelial cells (Majno 
and Palade, 1961). 
Marked differences in the extent of mast cell involvement in 
neurogenic inflammation exist among different organs and species 
and even among different strains of the same species (Chahl, 1988). 
Two examples will suffice: (i) in response to antidromic electrical 
nerve stimulation or injection of substance P, plasma leakage is 
increased in both the lower lip and in the tooth pulp of rats, but 
mast cells are involved only in the lower lip (Ohkubo et ai, 1993): 
(ii) mast cells play a role in neurogenic inflammation of the airways 
of some rat strains, but not in others (Germonpre et ai, 1995). 
MODULATION OF NEUROGENIC PLASMA LEAKAGE 
AND VASODILATATION 
Because of the obvious therapeutic potential, much attention has 
been devoted to regulating neurogenic inflammation. In principle, 
the inflammatory effects of sensory neuropeptides can be potenti­
ated or inhibited in several ways as listed in Table III. Presynaptic 
inhibition of sensory neuropeptide release can be induced by 
seemingly diverse molecules that hyperpolarize sensory nerve fibers 
by various ion channels (Barnes et ai, 1991). An interesting question 
is whether endogenous anti-inflammatory substances exist that 
inhibit sensory peptide release and, if so, whether they can be used 
therapeutically. A potential advantage of such treatment would be 
the ability to reduce the inflammation induced by many different 
stimuli. Preventing the release of multiple sensory nerve pep tides 
presynaptically may prove to be more effective than blocking the 
effects of individual pep tides postsynaptically by using multiple 
receptor antagonists. 
LEAKY BLOOD VESSELS AND ENDOTHELIAL GAPS 
The blood vessels that leak plasma in neurogenic inflammation are 
predominantly postcapillary venules and collecting venules; arte­
rioles and capillaries do not become leaky (Jancso et aI, 1967). The 
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endothelial basement membrane of leaky venules can be labeled 
histologically by the entrapment of intravenously injected particu­
late tracers such as colloidal silver or carbon or Monastral blue (Fig 
3A-q. The pattern of labeling of venules in neurogenic inflamma­
tion resembles that observed in the immediate response to inflam­
matory mediators such as histamine, bradykinin, and serotonin 
(Majno and Palade, 1961). As with these mediators, the plasma 
leakage in neurogenic inflammation results from an increase in the 
vascular permeability, due to the formation of gaps between 
endothelial cells (McDonald, 1994b). The endothelial gaps are 
small (average diameter of 0.3 to 0.5 jLm) and are focally distributed 
around the endothelial cell borders. The gaps can be recognized by 
light microscopy after silver nitrate staining (McDonald, 1994a; and 
Fig 3E), by lectin staining (Thurston et aI, 1996), and by scanning 
and transmission electron microscopy (Hirata et aI, 1995; Baluk et 
aI, 1997; and Fig 31'). The endothelial gaps are transient and fully 
reversible, so that the plasma leakage ends in a few minutes after the 
stimulus (McDonald, 1994a; Baluk et aI, 1997). 
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